Compare Abeona Therapeutics Inc (ABEO) vs ABRDN Physical Gold Shares ETF (SGOL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs ABRDN Physical Gold Shares ETF — how do they compare? Abeona Therapeutics Inc trades at $6.79 (market cap $373.32M), while ABRDN Physical Gold Shares ETF trades at $38.85. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, ABRDN Physical Gold Shares ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | SGOL | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $7.23 | $51.41 |
52-Week Low | $4.17 | $31.18 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
SGOL, a US-listed gold ETF, trades at $39.65, up 1.04% over the past 24 hours. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators remain neutral. Recent news highlights central bank gold buying and shifting Fed rate expectations as key drivers. The stock lacks fundamental ratios like P/E and P/B, typical for commodity ETFs tracking physical gold prices rather than corporate earnings.
The outlook for SGOL hinges on gold's safe-haven appeal amid economic uncertainty, with analysts forecasting potential price gains to $4,600-$5,500 per ounce by 2027. Risks include Fed policy shifts, dollar strength, and volatility from geopolitical events. Investor sentiment is cautiously optimistic due to institutional accumulation and ETF inflows.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About ABRDN Physical Gold Shares ETF
SGOL is an ETF that is designed to track the performance of the price of gold bullion. The fund is backed by physical gold held in secured vaults, which is allocated to the ETF's custodian account. By providing direct ownership of gold without the need for physical storage or insurance, SGOL offers investors a convenient and cost-effective way to gain exposure to the gold market.
Read more on SGOL →
